Vaishali Pharma Limited (NSE:VAISHALI)
India · Delayed Price · Currency is INR 6.51
+0.02 (0.31%)
Mar 10, 2026, 11:18 AM IST
Vaishali Pharma Market Cap
Vaishali Pharma has a market cap or net worth of 849.31 million as of March 9, 2026. Its market cap has decreased by -55.50% in one year.
Market Cap
849.31M
Enterprise Value
994.86M
Revenue
1.14B
Ranking
n/a
PE Ratio
n/a
Stock Price
6.51
Market Cap Chart
Since October 11, 2017, Vaishali Pharma's market cap has increased from 286.62M to 849.31M, an increase of 196.32%. That is a compound annual growth rate of 13.80%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 879.31M | -21.81% |
| Dec 31, 2025 | 1.12B | -46.84% |
| Dec 31, 2024 | 2.12B | 9.71% |
| Dec 29, 2023 | 1.93B | 31.85% |
| Dec 30, 2022 | 1.46B | 286.75% |
| Dec 31, 2021 | 378.08M | -48.82% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Oct 11, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Jagsonpal Pharmaceuticals | 11.59B |
| Beta Drugs | 11.08B |
| Sigachi Industries | 7.31B |
| Valiant Laboratories | 2.90B |
| Bafna Pharmaceuticals | 2.65B |
| Nectar Lifesciences | 2.27B |
| Brooks Laboratories | 1.80B |
| Alpa Laboratories | 1.34B |